Skip to main content
SAMIL PHARMACEUTICAL CO.,LTD logo

SAMIL PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000520 ISIN · KR7000520007 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2021-03-04 Proxy Solicitation & In…
Country KR South Korea
Listing KO 000520

About SAMIL PHARMACEUTICAL CO.,LTD

https://www.samil-pharm.com/main/EN

Samil Pharmaceutical Co., Ltd. is a company engaged in the research, development, and manufacturing of pharmaceutical products. The company specializes in ophthalmology and also produces a diverse portfolio of drugs for other therapeutic areas, including the central nervous system (CNS), hepatic conditions, and gastrointestinal disorders. Its product range encompasses prescription medicines as well as over-the-counter remedies for common ailments like fever and colds. In addition to developing its own products, Samil Pharmaceutical offers Contract Development and Manufacturing Organization (CDMO) services to global partners. The company emphasizes research and development and collaborates with other leading pharmaceutical firms.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It includes details on the meeting date, agenda items (such as approval of financial statements, appointment of directors, etc.), and instructions for electronic voting. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2021-03-04 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Samil Pharmaceutical regarding the decision to pay a cash dividend. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2021-02-23 Korean
주식분할결정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Samil Pharmaceutical regarding a 'Stock Split' (주식분할 결정). It details the change in par value per share, the increase in the total number of issued shares, the schedule for the shareholder meeting, and the effective date of the new shares. This falls under the category of capital changes and share structure adjustments.
2021-02-23 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Samil Pharmaceutical. It outlines the date, location, and agenda items (financial statements, stock split, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and the items to be voted upon.
2021-02-23 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a change in sales or profit structure (30% or more). It provides preliminary financial results (unaudited) for the fiscal year. This type of filing is a standard regulatory disclosure in the Korean market, often referred to as an 'Earnings Release' or 'Preliminary Financial Results' announcement. Since it provides key financial highlights and is an initial announcement of performance, it fits the 'Earnings Release' (ER) category. FY 2020
2021-01-21 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Samil Pharmaceutical Co., Ltd. for the third quarter of 2020 (January 1, 2020, to September 30, 2020). It contains detailed financial statements, business analysis, management discussion, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.